Global Neutropenia Biologic Drug Treatment Market Size, Status and Forecast 2024-2031

Report ID: 919290 | Published Date: Dec 2025 | No. of Page: 120 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Neutropenia Biologic Drug Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Filgrastim
        1.2.3 Pegfilgrastim
        1.2.4 Lenograstim
        1.2.5 Lipegfilgrastim
        1.2.6 Sargramostim
    1.3 Market by Application
        1.3.1 Global Neutropenia Biologic Drug Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Retail Pharmacies
        1.3.3 Hospital Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Neutropenia Biologic Drug Treatment Market Perspective (2016-2027)
    2.2 Neutropenia Biologic Drug Treatment Growth Trends by Regions
        2.2.1 Neutropenia Biologic Drug Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Neutropenia Biologic Drug Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Neutropenia Biologic Drug Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Neutropenia Biologic Drug Treatment Industry Dynamic
        2.3.1 Neutropenia Biologic Drug Treatment Market Trends
        2.3.2 Neutropenia Biologic Drug Treatment Market Drivers
        2.3.3 Neutropenia Biologic Drug Treatment Market Challenges
        2.3.4 Neutropenia Biologic Drug Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Neutropenia Biologic Drug Treatment Players by Revenue
        3.1.1 Global Top Neutropenia Biologic Drug Treatment Players by Revenue (2016-2021)
        3.1.2 Global Neutropenia Biologic Drug Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Neutropenia Biologic Drug Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Neutropenia Biologic Drug Treatment Revenue
    3.4 Global Neutropenia Biologic Drug Treatment Market Concentration Ratio
        3.4.1 Global Neutropenia Biologic Drug Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Neutropenia Biologic Drug Treatment Revenue in 2020
    3.5 Neutropenia Biologic Drug Treatment Key Players Head office and Area Served
    3.6 Key Players Neutropenia Biologic Drug Treatment Product Solution and Service
    3.7 Date of Enter into Neutropenia Biologic Drug Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Neutropenia Biologic Drug Treatment Breakdown Data by Type
    4.1 Global Neutropenia Biologic Drug Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Neutropenia Biologic Drug Treatment Forecasted Market Size by Type (2022-2027)

5 Neutropenia Biologic Drug Treatment Breakdown Data by Application
    5.1 Global Neutropenia Biologic Drug Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Neutropenia Biologic Drug Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Neutropenia Biologic Drug Treatment Market Size (2016-2027)
    6.2 North America Neutropenia Biologic Drug Treatment Market Size by Type
        6.2.1 North America Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021)
        6.2.2 North America Neutropenia Biologic Drug Treatment Market Size by Type (2022-2027)
        6.2.3 North America Neutropenia Biologic Drug Treatment Market Size by Type (2016-2027)
    6.3 North America Neutropenia Biologic Drug Treatment Market Size by Application
        6.3.1 North America Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021)
        6.3.2 North America Neutropenia Biologic Drug Treatment Market Size by Application (2022-2027)
        6.3.3 North America Neutropenia Biologic Drug Treatment Market Size by Application (2016-2027)
    6.4 North America Neutropenia Biologic Drug Treatment Market Size by Country
        6.4.1 North America Neutropenia Biologic Drug Treatment Market Size by Country (2016-2021)
        6.4.2 North America Neutropenia Biologic Drug Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Neutropenia Biologic Drug Treatment Market Size (2016-2027)
    7.2 Europe Neutropenia Biologic Drug Treatment Market Size by Type
        7.2.1 Europe Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Neutropenia Biologic Drug Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Neutropenia Biologic Drug Treatment Market Size by Type (2016-2027)
    7.3 Europe Neutropenia Biologic Drug Treatment Market Size by Application
        7.3.1 Europe Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Neutropenia Biologic Drug Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Neutropenia Biologic Drug Treatment Market Size by Application (2016-2027)
    7.4 Europe Neutropenia Biologic Drug Treatment Market Size by Country
        7.4.1 Europe Neutropenia Biologic Drug Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Neutropenia Biologic Drug Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Type
        8.2.1 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Application
        8.3.1 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Region
        8.4.1 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Neutropenia Biologic Drug Treatment Market Size (2016-2027)
    9.2 Latin America Neutropenia Biologic Drug Treatment Market Size by Type
        9.2.1 Latin America Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Neutropenia Biologic Drug Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Neutropenia Biologic Drug Treatment Market Size by Type (2016-2027)
    9.3 Latin America Neutropenia Biologic Drug Treatment Market Size by Application
        9.3.1 Latin America Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Neutropenia Biologic Drug Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Neutropenia Biologic Drug Treatment Market Size by Application (2016-2027)
    9.4 Latin America Neutropenia Biologic Drug Treatment Market Size by Country
        9.4.1 Latin America Neutropenia Biologic Drug Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Neutropenia Biologic Drug Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Type
        10.2.1 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Application
        10.3.1 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Country
        10.4.1 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Teva Pharmaceutical
        11.1.1 Teva Pharmaceutical Company Details
        11.1.2 Teva Pharmaceutical Business Overview
        11.1.3 Teva Pharmaceutical Neutropenia Biologic Drug Treatment Introduction
        11.1.4 Teva Pharmaceutical Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021)
        11.1.5 Teva Pharmaceutical Recent Development
    11.2 Amgen
        11.2.1 Amgen Company Details
        11.2.2 Amgen Business Overview
        11.2.3 Amgen Neutropenia Biologic Drug Treatment Introduction
        11.2.4 Amgen Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021)
        11.2.5 Amgen Recent Development
    11.3 Sanofi
        11.3.1 Sanofi Company Details
        11.3.2 Sanofi Business Overview
        11.3.3 Sanofi Neutropenia Biologic Drug Treatment Introduction
        11.3.4 Sanofi Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021)
        11.3.5 Sanofi Recent Development
    11.4 Mylan(Fulphila)
        11.4.1 Mylan(Fulphila) Company Details
        11.4.2 Mylan(Fulphila) Business Overview
        11.4.3 Mylan(Fulphila) Neutropenia Biologic Drug Treatment Introduction
        11.4.4 Mylan(Fulphila) Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021)
        11.4.5 Mylan(Fulphila) Recent Development
    11.5 Kyowa Kirin
        11.5.1 Kyowa Kirin Company Details
        11.5.2 Kyowa Kirin Business Overview
        11.5.3 Kyowa Kirin Neutropenia Biologic Drug Treatment Introduction
        11.5.4 Kyowa Kirin Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021)
        11.5.5 Kyowa Kirin Recent Development
    11.6 Novartis
        11.6.1 Novartis Company Details
        11.6.2 Novartis Business Overview
        11.6.3 Novartis Neutropenia Biologic Drug Treatment Introduction
        11.6.4 Novartis Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021)
        11.6.5 Novartis Recent Development
    11.7 Spectrum Pharmaceuticals
        11.7.1 Spectrum Pharmaceuticals Company Details
        11.7.2 Spectrum Pharmaceuticals Business Overview
        11.7.3 Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Introduction
        11.7.4 Spectrum Pharmaceuticals Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021)
        11.7.5 Spectrum Pharmaceuticals Recent Development
    11.8 Pfizer
        11.8.1 Pfizer Company Details
        11.8.2 Pfizer Business Overview
        11.8.3 Pfizer Neutropenia Biologic Drug Treatment Introduction
        11.8.4 Pfizer Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021)
        11.8.5 Pfizer Recent Development
    11.9 Baxter International
        11.9.1 Baxter International Company Details
        11.9.2 Baxter International Business Overview
        11.9.3 Baxter International Neutropenia Biologic Drug Treatment Introduction
        11.9.4 Baxter International Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021)
        11.9.5 Baxter International Recent Development
    11.10 Partner Therapeutics(Leukine)
        11.10.1 Partner Therapeutics(Leukine) Company Details
        11.10.2 Partner Therapeutics(Leukine) Business Overview
        11.10.3 Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Introduction
        11.10.4 Partner Therapeutics(Leukine) Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021)
        11.10.5 Partner Therapeutics(Leukine) Recent Development
    11.11 BeyondSpring Pharmaceuticals
        11.11.1 BeyondSpring Pharmaceuticals Company Details
        11.11.2 BeyondSpring Pharmaceuticals Business Overview
        11.11.3 BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Introduction
        11.11.4 BeyondSpring Pharmaceuticals Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021)
        11.11.5 BeyondSpring Pharmaceuticals Recent Development
    11.12 Cellerant Therapeutics
        11.12.1 Cellerant Therapeutics Company Details
        11.12.2 Cellerant Therapeutics Business Overview
        11.12.3 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Introduction
        11.12.4 Cellerant Therapeutics Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021)
        11.12.5 Cellerant Therapeutics Recent Development
    11.13 Enzychem Lifesciences Corporation
        11.13.1 Enzychem Lifesciences Corporation Company Details
        11.13.2 Enzychem Lifesciences Corporation Business Overview
        11.13.3 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Introduction
        11.13.4 Enzychem Lifesciences Corporation Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021)
        11.13.5 Enzychem Lifesciences Corporation Recent Development
    11.14 Myelo Therapeutics
        11.14.1 Myelo Therapeutics Company Details
        11.14.2 Myelo Therapeutics Business Overview
        11.14.3 Myelo Therapeutics Neutropenia Biologic Drug Treatment Introduction
        11.14.4 Myelo Therapeutics Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021)
        11.14.5 Myelo Therapeutics Recent Development
    11.15 Generon
        11.15.1 Generon Company Details
        11.15.2 Generon Business Overview
        11.15.3 Generon Neutropenia Biologic Drug Treatment Introduction
        11.15.4 Generon Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021)
        11.15.5 Generon Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Neutropenia Biologic Drug Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Filgrastim
    Table 3. Key Players of Pegfilgrastim
    Table 4. Key Players of Lenograstim
    Table 5. Key Players of Lipegfilgrastim
    Table 6. Key Players of Sargramostim
    Table 7. Global Neutropenia Biologic Drug Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Neutropenia Biologic Drug Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Neutropenia Biologic Drug Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Neutropenia Biologic Drug Treatment Market Share by Regions (2016-2021)
    Table 11. Global Neutropenia Biologic Drug Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Neutropenia Biologic Drug Treatment Market Share by Regions (2022-2027)
    Table 13. Neutropenia Biologic Drug Treatment Market Trends
    Table 14. Neutropenia Biologic Drug Treatment Market Drivers
    Table 15. Neutropenia Biologic Drug Treatment Market Challenges
    Table 16. Neutropenia Biologic Drug Treatment Market Restraints
    Table 17. Global Neutropenia Biologic Drug Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Neutropenia Biologic Drug Treatment Market Share by Players (2016-2021)
    Table 19. Global Top Neutropenia Biologic Drug Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neutropenia Biologic Drug Treatment as of 2020)
    Table 20. Ranking of Global Top Neutropenia Biologic Drug Treatment Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Neutropenia Biologic Drug Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Neutropenia Biologic Drug Treatment Product Solution and Service
    Table 24. Date of Enter into Neutropenia Biologic Drug Treatment Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Type (2016-2021)
    Table 28. Global Neutropenia Biologic Drug Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Neutropenia Biologic Drug Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Application (2016-2021)
    Table 32. Global Neutropenia Biologic Drug Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Neutropenia Biologic Drug Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Neutropenia Biologic Drug Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Neutropenia Biologic Drug Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Neutropenia Biologic Drug Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Neutropenia Biologic Drug Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Neutropenia Biologic Drug Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Neutropenia Biologic Drug Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Neutropenia Biologic Drug Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Neutropenia Biologic Drug Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Neutropenia Biologic Drug Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Neutropenia Biologic Drug Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Neutropenia Biologic Drug Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Teva Pharmaceutical Company Details
    Table 65. Teva Pharmaceutical Business Overview
    Table 66. Teva Pharmaceutical Neutropenia Biologic Drug Treatment Product
    Table 67. Teva Pharmaceutical Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021) & (US$ Million)
    Table 68. Teva Pharmaceutical Recent Development
    Table 69. Amgen Company Details
    Table 70. Amgen Business Overview
    Table 71. Amgen Neutropenia Biologic Drug Treatment Product
    Table 72. Amgen Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021) & (US$ Million)
    Table 73. Amgen Recent Development
    Table 74. Sanofi Company Details
    Table 75. Sanofi Business Overview
    Table 76. Sanofi Neutropenia Biologic Drug Treatment Product
    Table 77. Sanofi Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021) & (US$ Million)
    Table 78. Sanofi Recent Development
    Table 79. Mylan(Fulphila) Company Details
    Table 80. Mylan(Fulphila) Business Overview
    Table 81. Mylan(Fulphila) Neutropenia Biologic Drug Treatment Product
    Table 82. Mylan(Fulphila) Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021) & (US$ Million)
    Table 83. Mylan(Fulphila) Recent Development
    Table 84. Kyowa Kirin Company Details
    Table 85. Kyowa Kirin Business Overview
    Table 86. Kyowa Kirin Neutropenia Biologic Drug Treatment Product
    Table 87. Kyowa Kirin Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021) & (US$ Million)
    Table 88. Kyowa Kirin Recent Development
    Table 89. Novartis Company Details
    Table 90. Novartis Business Overview
    Table 91. Novartis Neutropenia Biologic Drug Treatment Product
    Table 92. Novartis Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021) & (US$ Million)
    Table 93. Novartis Recent Development
    Table 94. Spectrum Pharmaceuticals Company Details
    Table 95. Spectrum Pharmaceuticals Business Overview
    Table 96. Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Product
    Table 97. Spectrum Pharmaceuticals Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021) & (US$ Million)
    Table 98. Spectrum Pharmaceuticals Recent Development
    Table 99. Pfizer Company Details
    Table 100. Pfizer Business Overview
    Table 101. Pfizer Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021) & (US$ Million)
    Table 102. Pfizer Recent Development
    Table 103. Baxter International Company Details
    Table 104. Baxter International Business Overview
    Table 105. Baxter International Neutropenia Biologic Drug Treatment Product
    Table 106. Baxter International Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021) & (US$ Million)
    Table 107. Baxter International Recent Development
    Table 108. Partner Therapeutics(Leukine) Company Details
    Table 109. Partner Therapeutics(Leukine) Business Overview
    Table 110. Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Product
    Table 111. Partner Therapeutics(Leukine) Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021) & (US$ Million)
    Table 112. Partner Therapeutics(Leukine) Recent Development
    Table 113. BeyondSpring Pharmaceuticals Company Details
    Table 114. BeyondSpring Pharmaceuticals Business Overview
    Table 115. BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Product
    Table 116. BeyondSpring Pharmaceuticals Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021) & (US$ Million)
    Table 117. BeyondSpring Pharmaceuticals Recent Development
    Table 118. Cellerant Therapeutics Company Details
    Table 119. Cellerant Therapeutics Business Overview
    Table 120. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product
    Table 121. Cellerant Therapeutics Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021) & (US$ Million)
    Table 122. Cellerant Therapeutics Recent Development
    Table 123. Enzychem Lifesciences Corporation Company Details
    Table 124. Enzychem Lifesciences Corporation Business Overview
    Table 125. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product
    Table 126. Enzychem Lifesciences Corporation Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021) & (US$ Million)
    Table 127. Enzychem Lifesciences Corporation Recent Development
    Table 128. Myelo Therapeutics Company Details
    Table 129. Myelo Therapeutics Business Overview
    Table 130. Myelo Therapeutics Neutropenia Biologic Drug Treatment Product
    Table 131. Myelo Therapeutics Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021) & (US$ Million)
    Table 132. Myelo Therapeutics Recent Development
    Table 133. Generon Company Details
    Table 134. Generon Business Overview
    Table 135. Generon Neutropenia Biologic Drug Treatment Product
    Table 136. Generon Revenue in Neutropenia Biologic Drug Treatment Business (2016-2021) & (US$ Million)
    Table 137. Generon Recent Development
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neutropenia Biologic Drug Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Filgrastim Features
    Figure 3. Pegfilgrastim Features
    Figure 4. Lenograstim Features
    Figure 5. Lipegfilgrastim Features
    Figure 6. Sargramostim Features
    Figure 7. Global Neutropenia Biologic Drug Treatment Market Share by Application: 2020 VS 2027
    Figure 8. Retail Pharmacies Case Studies
    Figure 9. Hospital Pharmacies Case Studies
    Figure 10. Online Pharmacies Case Studies
    Figure 11. Neutropenia Biologic Drug Treatment Report Years Considered
    Figure 12. Global Neutropenia Biologic Drug Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Neutropenia Biologic Drug Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Neutropenia Biologic Drug Treatment Market Share by Regions: 2020 VS 2027
    Figure 15. Global Neutropenia Biologic Drug Treatment Market Share by Regions (2022-2027)
    Figure 16. Global Neutropenia Biologic Drug Treatment Market Share by Players in 2020
    Figure 17. Global Top Neutropenia Biologic Drug Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neutropenia Biologic Drug Treatment as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Neutropenia Biologic Drug Treatment Revenue in 2020
    Figure 19. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Type (2016-2021)
    Figure 20. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Type (2022-2027)
    Figure 21. North America Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Neutropenia Biologic Drug Treatment Market Share by Type (2016-2027)
    Figure 23. North America Neutropenia Biologic Drug Treatment Market Share by Application (2016-2027)
    Figure 24. North America Neutropenia Biologic Drug Treatment Market Share by Country (2016-2027)
    Figure 25. United States Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Neutropenia Biologic Drug Treatment Market Share by Type (2016-2027)
    Figure 29. Europe Neutropenia Biologic Drug Treatment Market Share by Application (2016-2027)
    Figure 30. Europe Neutropenia Biologic Drug Treatment Market Share by Country (2016-2027)
    Figure 31. Germany Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Neutropenia Biologic Drug Treatment Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Neutropenia Biologic Drug Treatment Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Neutropenia Biologic Drug Treatment Market Share by Region (2016-2027)
    Figure 41. China Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Neutropenia Biologic Drug Treatment Market Share by Type (2016-2027)
    Figure 49. Latin America Neutropenia Biologic Drug Treatment Market Share by Application (2016-2027)
    Figure 50. Latin America Neutropenia Biologic Drug Treatment Market Share by Country (2016-2027)
    Figure 51. Mexico Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Neutropenia Biologic Drug Treatment Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Neutropenia Biologic Drug Treatment Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Neutropenia Biologic Drug Treatment Market Share by Country (2016-2027)
    Figure 57. Turkey Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Neutropenia Biologic Drug Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Teva Pharmaceutical Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2016-2021)
    Figure 61. Amgen Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2016-2021)
    Figure 62. Sanofi Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2016-2021)
    Figure 63. Mylan(Fulphila) Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2016-2021)
    Figure 64. Kyowa Kirin Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2016-2021)
    Figure 65. Novartis Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2016-2021)
    Figure 66. Spectrum Pharmaceuticals Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2016-2021)
    Figure 67. Pfizer Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2016-2021)
    Figure 68. Baxter International Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2016-2021)
    Figure 69. Partner Therapeutics(Leukine) Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2016-2021)
    Figure 70. BeyondSpring Pharmaceuticals Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2016-2021)
    Figure 71. Cellerant Therapeutics Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2016-2021)
    Figure 72. Enzychem Lifesciences Corporation Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2016-2021)
    Figure 73. Myelo Therapeutics Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2016-2021)
    Figure 74. Generon Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2016-2021)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Teva Pharmaceutical
Amgen
Sanofi
Mylan(Fulphila)
Kyowa Kirin
Novartis
Spectrum Pharmaceuticals
Pfizer
Baxter International
Partner Therapeutics(Leukine)
BeyondSpring Pharmaceuticals
Cellerant Therapeutics
Enzychem Lifesciences Corporation
Myelo Therapeutics
Generon
Frequently Asked Questions
Neutropenia Biologic Drug Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neutropenia Biologic Drug Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neutropenia Biologic Drug Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Inhalation Sedatives

Inhalation Sedatives are the drugs used to induce or maintain inhalation sedation, which is a typ ... Read More